Figure 9
From: The pan-cancer landscape of netrin family reveals potential oncogenic biomarkers

Netrins in pathways and sensitivity to drugs. (a) Global percentage shows percentage of gene’s function (activation or inhibition) for each pathway in all cancers. (b) Heatmap show netrin family members that have function (inhibit or activate) in at least 5 cancer types. Pathway A represent activation of this pathway, inhibition in a similar way showed as pathway I. (c) Heatmap of drug sensitivity / tolerance of netrins with high expression.